| __timestamp | Axsome Therapeutics, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 13673000 |
| Thursday, January 1, 2015 | 6776987 | 14358000 |
| Friday, January 1, 2016 | 21199860 | 12203000 |
| Sunday, January 1, 2017 | 19957616 | 18125000 |
| Monday, January 1, 2018 | 23495055 | 17071000 |
| Tuesday, January 1, 2019 | 53647067 | 20018000 |
| Wednesday, January 1, 2020 | 70244579 | 32788000 |
| Friday, January 1, 2021 | 58060725 | 44966000 |
| Saturday, January 1, 2022 | 57947447 | 311681000 |
| Sunday, January 1, 2023 | 97944000 | 77707000 |
Igniting the spark of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Lantheus Holdings, Inc. and Axsome Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Axsome Therapeutics, Inc. increased its R&D spending by over 2,000%, peaking in 2023 with a remarkable 98 million dollars. This surge underscores Axsome's aggressive pursuit of groundbreaking therapies. In contrast, Lantheus Holdings, Inc. exhibited a more measured approach, with a notable spike in 2022, where R&D expenses soared to 312 million dollars, a 900% increase from 2014.
These trends highlight the dynamic nature of R&D investments in the biotech sector, reflecting each company's strategic priorities and their potential impact on future healthcare innovations.
Research and Development Expenses Breakdown: argenx SE vs Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: Genmab A/S vs Lantheus Holdings, Inc.
Research and Development: Comparing Key Metrics for Incyte Corporation and Lantheus Holdings, Inc.
R&D Insights: How Bio-Techne Corporation and Lantheus Holdings, Inc. Allocate Funds
Research and Development Investment: Lantheus Holdings, Inc. vs Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and ADMA Biologics, Inc.
R&D Insights: How Lantheus Holdings, Inc. and Soleno Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Mesoblast Limited
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.
Axsome Therapeutics, Inc. or BioCryst Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Investment: Axsome Therapeutics, Inc. vs Novavax, Inc.